Back

Answers in CME Inc. (AiCME)

  • Combined Modality Therapy
  • Treatment Outcome

From Evidence to Impact: Leveraging the Latest Data to Elevate Standards and Patient Outcomes in mHSPC

This enduring activity highlights two experts discussing the latest data in evaluating emerging evidence on combination therapies for mHSPC and applying it to everyday practice through structured, peer-driven learning. As a result of this educational curriculum, learners will be better able to: 1. Evaluate the clinical implications of the most recent data informing the standard of care treatment options for mHSPC; 2. Integrate patient-, disease-, and therapy-related factors to develop individualized, evidence-based treatment strategies for mHSPC; and, 3. Design patient-centered care approaches that balance the benefit and risk of treatment to optimize outcomes in mHSPC. Learners have access to downloadable materials for future use in practice.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Microlearning
  • includes Online course / module
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    Aug 3, 2026
  • Last day to claim credit
    Aug 3, 2027 10 months left